Pharmaceuticals
Ireland’s Horizon Pharma launches $3-bn hostile buyout bid for US rival Depomed
08 Jul 2015
The combined entity will have 13 marketed drugs, which nearly doubles Horizon’s current portfolio of seven,and is expected to result in 2015 net sales of over $950 million
Teva plans to raise bid for rival drugmaker Mylan to $42 bn
07 Jul 2015
Teva and Mylan's product offerings are highly complementary and, together, would create the broadest portfolio in the global pharmaceuticals industry, with a combined pipeline of over 400 applications for new drugs
Biogen ventures into ophthalmology with $1-bn AGTC tie-up
04 Jul 2015
The collaboration will focus on the development of a portfolio of therapeutic programmes for orphan diseases of the retina that can lead to blindness in children and adults
US claims $3.3 bn in Novartis kickback lawsuit
01 Jul 2015
Novartis is accused of referring patients to specialty pharmacies and paying kickbacks in the form of rebates to get them to recommend the drugs to patients to boost sales
Novartis to buy chronic pain drug developer Spinifex Pharmaceuticals
29 Jun 2015
Founded in 2005 and based in Stamford, Connecticut, USA, and Melbourne, Australia, Spinifex’ lead product is EMA401, under development as a potential first-in-class oral treatment for chronic pain without CNS side effects
Eli Lilly wins key cancer drug patent case in UK
26 Jun 2015
Government launches pharma price data bank
25 Jun 2015
Botox-maker Allergan Plc to buy Kythera Biopharmaceuticals for $2.1 bn
18 Jun 2015
Botox-maker Allergan Plc yesterday struck a deal to buy Kythera Biopharmaceuticals Inc in a $2.1-billion cash-and-stock deal, in a bid to expand its portfolio of cosmetic treatments
Abbott Laboratories to back Mylan-Perrigo deal
17 Jun 2015
EU conditional nod for Merck's $17-bn purchase of Sigma-Aldrich
16 Jun 2015
Sigma-Aldrich is a life science and technology company that manufactures and distributes more than 230,000 chemicals, biochemicals and other essential products globally to research and applied labs as well as in industrial and commercial markets
Featured articles
![](/Uploads/Images/thumb_733d509d-493c-41e9-b429-1260d912bb91-Aerogel-Crayon.jpg)
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
![](/Uploads/Images/thumb_294b0bec-6ff0-43c9-9fbc-a14e7cc70fa5-COP28.jpg)
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
![](/Uploads/Images/thumb_97943c9b-6e8f-429b-b355-1d4502bac437-Ponzi-Money.jpg)
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
![](/Uploads/Images/thumb_0f8359a3-2528-4faf-86c9-707fb7bccc01-Hdfc-logo.jpg)
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
![](/Uploads/Images/thumb_dc6b9dcc-e31e-4574-82e7-928e089406e0-Finger_millet.jpg)
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
![](/Uploads/Images/thumb_e37827da-fafd-4991-8635-60fade3df34c-ICM.jpg)
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation